Screener
CG Oncology CGON Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's shares (diluted)?
- CG Oncology (CGON) reported shares (diluted) of 88.2M in Q2 2026.
- How has CG Oncology's shares (diluted) changed year-over-year?
- CG Oncology's shares (diluted) increased by 15.7% year-over-year, from 76.2M to 88.2M.
- What is the long-term trend for CG Oncology's shares (diluted)?
- Over 2 years (2023 to 2025), CG Oncology's shares (diluted) has grown at a 331.1% compound annual growth rate (CAGR), from 16.5M to 306.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about CG Oncology's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude